Akeso, Inc. (HKG:9926)
Hong Kong · Delayed Price · Currency is HKD 155.60
+5.00 (3.32%)
Jul 29, 2025, 4:08 PM HKT
Akeso Market Cap
Akeso has a market cap or net worth of 139.66 billion as of July 29, 2025. Its market cap has increased by 314.65% in one year.
Market Cap
139.66B
Enterprise Value
135.98B
Revenue
2.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
155.60
Market Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 139.66B, an increase of 653.14%. That is a compound annual growth rate of 46.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2025 | 139.66B | 156.34% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | 29.91B | 61.28% |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 271.47B |
| Hansoh Pharmaceutical Group Company | 203.94B |
| JD Health International | 154.09B |
| Innovent Biologics | 152.40B |
| WuXi Biologics | 128.18B |
| Sino Biopharmaceutical | 121.08B |
| CSPC Pharmaceutical Group | 98.67B |
| Sichuan Kelun-Biotech Biopharmaceutical | 84.65B |